288 related articles for article (PubMed ID: 31959478)
21. LncRNA PITPNA-AS1 promotes gastric cancer by increasing SOX4 expression via inhibition of miR-92a-3p.
Liu L; Dai A; Zhang Z; Ning M; Han D; Li L; Li Z
Aging (Albany NY); 2021 Sep; 13(17):21191-21201. PubMed ID: 34496348
[TBL] [Abstract][Full Text] [Related]
22. LncRNA ZEB2-AS1 promotes the proliferation, migration and invasion of esophageal squamous cell carcinoma cell through miR-574-3p/HMGA2 axis.
Xu JH; Chen RZ; Liu LY; Li XM; Wu CP; Zhou YT; Yan JD; Zhang ZY
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5391-5403. PubMed ID: 32495874
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of long non-coding RNA Opa interacting protein 5-antisense RNA 1 inhibits breast cancer progression by targeting sex-determining region Y-box 2 by microRNA-129-5p upregulation.
Zeng H; Wang J; Chen T; Zhang K; Chen J; Wang L; Li H; Tuluhong D; Li J; Wang S
Cancer Sci; 2019 Jan; 110(1):289-302. PubMed ID: 30443959
[TBL] [Abstract][Full Text] [Related]
24. LncRNA OIP5-AS1 inhibits ferroptosis in prostate cancer with long-term cadmium exposure through miR-128-3p/SLC7A11 signaling.
Zhang Y; Guo S; Wang S; Li X; Hou D; Li H; Wang L; Xu Y; Ma B; Wang H; Jiang X
Ecotoxicol Environ Saf; 2021 Sep; 220():112376. PubMed ID: 34051661
[TBL] [Abstract][Full Text] [Related]
25. LBX2-AS1/miR-219a-2-3p/FUS/LBX2 positive feedback loop contributes to the proliferation of gastric cancer.
Yang Z; Dong X; Pu M; Yang H; Chang W; Ji F; Liu T; Wei C; Zhang X; Qiu X
Gastric Cancer; 2020 May; 23(3):449-463. PubMed ID: 31673844
[TBL] [Abstract][Full Text] [Related]
26. Cancer-associated fibroblasts-derived exosomes promote lung cancer progression by OIP5-AS1/ miR-142-5p/ PD-L1 axis.
Jiang Y; Wang K; Lu X; Wang Y; Chen J
Mol Immunol; 2021 Dec; 140():47-58. PubMed ID: 34653794
[TBL] [Abstract][Full Text] [Related]
27. LncRNA OIP5-AS1 accelerates intervertebral disc degeneration by targeting miR-25-3p.
Che Z; Xueqin J; Zhang Z
Bioengineered; 2021 Dec; 12(2):11201-11212. PubMed ID: 34872452
[TBL] [Abstract][Full Text] [Related]
28. Long non-coding RNA OIP5-AS1 promotes proliferation of gastric cancer cells by targeting miR-641.
Wang LW; Li XB; Liu Z; Zhao LH; Wang Y; Yue L
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10776-10784. PubMed ID: 31858545
[TBL] [Abstract][Full Text] [Related]
29. LncRNA OIP5-AS1/miR-410-3p/Wnt7b axis promotes the proliferation of rheumatoid arthritis fibroblast-like synoviocytes via regulating the Wnt/β-catenin pathway.
Sun Y; Jiang H; Pan L; Han Y; Chen Y; Jiang Y; Wang Y
Autoimmunity; 2023 Dec; 56(1):2189136. PubMed ID: 36942896
[TBL] [Abstract][Full Text] [Related]
30. N6-methyladenosine modification of OIP5-AS1 promotes glycolysis, tumorigenesis, and metastasis of gastric cancer by inhibiting Trim21-mediated hnRNPA1 ubiquitination and degradation.
Xie R; Liu L; Lu X; He C; Yao H; Li G
Gastric Cancer; 2024 Jan; 27(1):49-71. PubMed ID: 37897508
[TBL] [Abstract][Full Text] [Related]
31. LncRNA-HNF1A-AS1 functions as a competing endogenous RNA to activate PI3K/AKT signalling pathway by sponging miR-30b-3p in gastric cancer.
Liu HT; Ma RR; Lv BB; Zhang H; Shi DB; Guo XY; Zhang GH; Gao P
Br J Cancer; 2020 Jun; 122(12):1825-1836. PubMed ID: 32336754
[TBL] [Abstract][Full Text] [Related]
32. Effects of long non-coding RNA Opa-interacting protein 5 antisense RNA 1 on colon cancer cell resistance to oxaliplatin and its regulation of microRNA-137.
Liang J; Tian XF; Yang W
World J Gastroenterol; 2020 Apr; 26(13):1474-1489. PubMed ID: 32308348
[TBL] [Abstract][Full Text] [Related]
33. A review on the role of oncogenic lncRNA OIP5-AS1 in human malignancies.
Ghafouri-Fard S; Dashti S; Farsi M; Hussen BM; Taheri M
Biomed Pharmacother; 2021 May; 137():111366. PubMed ID: 33601149
[TBL] [Abstract][Full Text] [Related]
34. LncRNA NCK1-AS1 exerts oncogenic property in gastric cancer by targeting the miR-22-3p/BCL9 axis to activate the Wnt/β-catenin signaling.
Guan B; Ma J; Yang Z; Yu F; Yao J
Environ Toxicol; 2021 Aug; 36(8):1640-1653. PubMed ID: 33974352
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
36. Suppression of lncRNA OIP5-AS1 Attenuates Apoptosis and Inflammation, and Promotes Proliferation by Mediating miR-25-3p Expression in Lipopolysaccharide-Induced Myocardial Injury.
Ma J; Qian H; Zou H
Anal Cell Pathol (Amst); 2023; 2023():3154223. PubMed ID: 36994450
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA OIP5-AS1 aggravates cell proliferation, migration in gastric cancer by epigenetically silencing NLRP6 expression via binding EZH2.
Bai Y; Li S
J Cell Biochem; 2020 Jan; 121(1):353-362. PubMed ID: 31219209
[TBL] [Abstract][Full Text] [Related]
38. Long non-coding RNA OIP5-AS1 serves as an oncogene in laryngeal squamous cell carcinoma by regulating miR-204-5p/ZEB1 axis.
Wang H; Qian J; Xia X; Ye B
Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2177-2184. PubMed ID: 32009213
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
Zhang ZB; Liu N
Aging (Albany NY); 2021 Aug; 13(16):20820-20835. PubMed ID: 34461605
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA OIP5-AS1 accelerates CDK14 expression to promote osteosarcoma tumorigenesis via targeting miR-223.
Dai J; Xu L; Hu X; Han G; Jiang H; Sun H; Zhu G; Tang X
Biomed Pharmacother; 2018 Oct; 106():1441-1447. PubMed ID: 30119217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
